Patent details
91676 Product Name: "Valsartan, amlodipine et hydrochlorothiazide et leur sel pharmaceutiquement acceptable - EXFORGE HCT®"
Basic Information
- Publication number:
- 91676
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP918100983
- Legal Status:
- Lapsed
- Application number:
- 91676
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- 59407 (01-05) - EXFORGE HCT
- Marketing Authorization Type:
- Marketing Authorization Date:
- 16/09/2009
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Switzerland (CH)
2
- Marketing Authorization Number:
- EU/1/09/569/001-060 - EXFORGE HTC
- Marketing Authorization Type:
- Marketing Authorization Date:
- 16/10/2009
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 07/04/2010
- First Marketing Authorization date:
- 16/09/2009
- Grant date:
- 07/06/2010
- Activation date:
- 12/02/2011
- Publication date:
- 07/06/2010
- Lapsed date:
- Expiration date:
- Renunciation date:
- 09/03/2012
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 12/02/2016
- SPC Extension Expiration:
- 12/02/2016
- Rejection date:
- Withdrawal date:
Owner
- From:
- 07/04/2010
- Name:
- NOVARTIS AG
- Address:
- LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 07/04/2010
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Ostermayer Franz, Dr.
- Address:
- Switzerland (CH)
2
- Name:
- BÜhlmayer Peter, Dr.
- Address:
- Switzerland (CH)
3
- Name:
- Schmidlin Tibur, Dr.
- Address:
- Switzerland (CH)
| Filing date | Document type | Number of pages |
|---|